Loren Mell, Md

This study compares two treatments for people with advanced p16-positive head and neck cancer. One group gets radiation plus the immunotherapy drug pembrolizumab (Keytruda), while the other gets radiation plus standard chemotherapy. The goal is to see if the immunotherapy approac…